
Laurie A. Scheiner
Examiner (ID: 12886)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1812, 1802, 1648, 1813, 1807, 1641 |
| Total Applications | 650 |
| Issued Applications | 403 |
| Pending Applications | 88 |
| Abandoned Applications | 159 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1080225
[patent_doc_number] => 06835383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-28
[patent_title] => 'Protein kinase deficient, immunologically active CMVpp65 mutants'
[patent_app_type] => B2
[patent_app_number] => 09/815330
[patent_app_country] => US
[patent_app_date] => 2001-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8720
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835383.pdf
[firstpage_image] =>[orig_patent_app_number] => 09815330
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/815330 | Protein kinase deficient, immunologically active CMVpp65 mutants | Mar 22, 2001 | Issued |
Array
(
[id] => 6548787
[patent_doc_number] => 20020137918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Immunoglobulin binding protein'
[patent_app_type] => new
[patent_app_number] => 09/808212
[patent_app_country] => US
[patent_app_date] => 2001-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10734
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137918.pdf
[firstpage_image] =>[orig_patent_app_number] => 09808212
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/808212 | Immunoglobulin binding protein | Mar 12, 2001 | Issued |
Array
(
[id] => 1469530
[patent_doc_number] => 06406870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-06-18
[patent_title] => 'Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes'
[patent_app_type] => B2
[patent_app_number] => 09/798267
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 5
[patent_no_of_words] => 26979
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/406/06406870.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798267
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798267 | Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes | Mar 1, 2001 | Issued |
Array
(
[id] => 1391463
[patent_doc_number] => 06544928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-08
[patent_title] => 'VIRUS CAPABLE OF SPECIFICALLY INFECTING, GROWING WITHIN, AND LYSING RED TIDE PLANKTON; A METHOD AND AN AGENT FOR PREVENTING RED TIDE USING THE VIRUS; A METHOD FOR ISOLATING THE VIRUS; AND A METHOD FOR SUBCULTURING THE VIRUS'
[patent_app_type] => B2
[patent_app_number] => 09/789611
[patent_app_country] => US
[patent_app_date] => 2001-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5159
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/544/06544928.pdf
[firstpage_image] =>[orig_patent_app_number] => 09789611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/789611 | VIRUS CAPABLE OF SPECIFICALLY INFECTING, GROWING WITHIN, AND LYSING RED TIDE PLANKTON; A METHOD AND AN AGENT FOR PREVENTING RED TIDE USING THE VIRUS; A METHOD FOR ISOLATING THE VIRUS; AND A METHOD FOR SUBCULTURING THE VIRUS | Feb 21, 2001 | Issued |
Array
(
[id] => 6618699
[patent_doc_number] => 20020086022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Neutralizing antibody and immunomodulatory enhancing compositions'
[patent_app_type] => new
[patent_app_number] => 09/780773
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10691
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780773
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780773 | Neutralizing antibody and immunomodulatory enhancing compositions | Feb 8, 2001 | Abandoned |
Array
(
[id] => 5800849
[patent_doc_number] => 20020009447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Prophylactic and therapeutic monoclonal antibodies'
[patent_app_type] => new
[patent_app_number] => 09/781124
[patent_app_country] => US
[patent_app_date] => 2001-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5921
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009447.pdf
[firstpage_image] =>[orig_patent_app_number] => 09781124
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/781124 | Prophylactic and therapeutic monoclonal antibodies | Feb 8, 2001 | Issued |
Array
(
[id] => 935228
[patent_doc_number] => 06974577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-13
[patent_title] => 'Inactivated bovine scours vaccines, processes and method of preventing bovine scours'
[patent_app_type] => utility
[patent_app_number] => 09/776787
[patent_app_country] => US
[patent_app_date] => 2001-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7318
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/974/06974577.pdf
[firstpage_image] =>[orig_patent_app_number] => 09776787
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/776787 | Inactivated bovine scours vaccines, processes and method of preventing bovine scours | Feb 3, 2001 | Issued |
Array
(
[id] => 6242196
[patent_doc_number] => 20020045219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Production of human monoclonal antibodies'
[patent_app_type] => new
[patent_app_number] => 09/759984
[patent_app_country] => US
[patent_app_date] => 2001-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18783
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045219.pdf
[firstpage_image] =>[orig_patent_app_number] => 09759984
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/759984 | Production of human monoclonal antibodies | Jan 11, 2001 | Abandoned |
Array
(
[id] => 1129288
[patent_doc_number] => 06787140
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B1
[patent_app_number] => 09/724489
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 26489
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787140.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724489
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724489 | Prevention and treatment of amyloidogenic disease | Nov 27, 2000 | Issued |
Array
(
[id] => 1129279
[patent_doc_number] => 06787139
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B1
[patent_app_number] => 09/724102
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 26478
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787139.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724102
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724102 | Prevention and treatment of amyloidogenic disease | Nov 27, 2000 | Issued |
Array
(
[id] => 1129249
[patent_doc_number] => 06787138
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B1
[patent_app_number] => 09/723927
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 26481
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787138.pdf
[firstpage_image] =>[orig_patent_app_number] => 09723927
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/723927 | Prevention and treatment of amyloidogenic disease | Nov 27, 2000 | Issued |
Array
(
[id] => 1129347
[patent_doc_number] => 06787143
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B1
[patent_app_number] => 09/724477
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 26452
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787143.pdf
[firstpage_image] =>[orig_patent_app_number] => 09724477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724477 | Prevention and treatment of amyloidogenic disease | Nov 27, 2000 | Issued |
Array
(
[id] => 4377141
[patent_doc_number] => 06294173
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein'
[patent_app_type] => 1
[patent_app_number] => 9/724404
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21515
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294173.pdf
[firstpage_image] =>[orig_patent_app_number] => 724404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/724404 | Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein | Nov 27, 2000 | Issued |
Array
(
[id] => 1129350
[patent_doc_number] => 06787144
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-07
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => B1
[patent_app_number] => 09/723762
[patent_app_country] => US
[patent_app_date] => 2000-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 26403
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/787/06787144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09723762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/723762 | Prevention and treatment of amyloidogenic disease | Nov 27, 2000 | Issued |
Array
(
[id] => 1383933
[patent_doc_number] => 06544518
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-08
[patent_title] => 'Vaccines'
[patent_app_type] => B1
[patent_app_number] => 09/690921
[patent_app_country] => US
[patent_app_date] => 2000-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 15130
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/544/06544518.pdf
[firstpage_image] =>[orig_patent_app_number] => 09690921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/690921 | Vaccines | Oct 17, 2000 | Issued |
Array
(
[id] => 1005086
[patent_doc_number] => 06905677
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-14
[patent_title] => 'Combined hepatitis B treatment'
[patent_app_type] => utility
[patent_app_number] => 09/689637
[patent_app_country] => US
[patent_app_date] => 2000-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2015
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/905/06905677.pdf
[firstpage_image] =>[orig_patent_app_number] => 09689637
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/689637 | Combined hepatitis B treatment | Oct 12, 2000 | Issued |
Array
(
[id] => 4348854
[patent_doc_number] => 06291197
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Binding moieties for human parvovirus B19'
[patent_app_type] => 1
[patent_app_number] => 9/669271
[patent_app_country] => US
[patent_app_date] => 2000-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10339
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/291/06291197.pdf
[firstpage_image] =>[orig_patent_app_number] => 669271
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/669271 | Binding moieties for human parvovirus B19 | Sep 25, 2000 | Issued |
| 09/463840 | AGENT FOR EXPRESSING AND DETECTING A FUSION POLYPEPTIDE WITH AN HPOL-EPITOPE AND A POLYPEPTIDE | Jul 16, 2000 | Abandoned |
| 09/579933 | Traf inhibitors | May 25, 2000 | Abandoned |
Array
(
[id] => 1457745
[patent_doc_number] => 06391304
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications'
[patent_app_type] => B1
[patent_app_number] => 09/529377
[patent_app_country] => US
[patent_app_date] => 2000-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7508
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09529377
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529377 | Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications | May 18, 2000 | Issued |